Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

news.google.com

Biogen - Google News

Get the latest updates from Biogen - Google News directly as they happen.

Follow now < 10 followers

Latest posts

Last updated about 3 hours ago

Biogen’s Litifilimab Study: A Long-Term Look at SLE Treatment - The Globe and Mail

about 20 hours ago

Biogen’s Litifilimab Study: A Long-Term Look at SLE Treatment  The Globe and...

Biogen’s Felzartamab Study: A Potential Game-Changer for IgA Nephropathy - TipRanks

about 20 hours ago

Biogen’s Felzartamab Study: A Potential Game-Changer for IgA Nephropathy  TipRanks

Kintegral Advisory LLC Lowers Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

about 23 hours ago

Kintegral Advisory LLC Lowers Position in Biogen Inc. (NASDAQ:BIIB)  MarketBeat

Genentech's $122M MS Drug Royalties Case Ends In Mistrial - Law360

1 day ago

Genentech's $122M MS Drug Royalties Case Ends In Mistrial  Law360

Genentech's $122M MS Drug Royalties Case Ends In Mistrial - Law360

1 day ago

Genentech's $122M MS Drug Royalties Case Ends In Mistrial  Law360

Biogen’s Promising Phase 3 Trial: Felzartamab for Kidney Transplant Rejection - TipRanks

2 days ago

Biogen’s Promising Phase 3 Trial: Felzartamab for Kidney Transplant Rejection  TipRanks

Biogen’s Litifilimab Study: A Long-Term Look at SLE Treatment - TipRanks

2 days ago

Biogen’s Litifilimab Study: A Long-Term Look at SLE Treatment  TipRanks

Biogen’s Pivotal Study on ThecaFlex DRx™ System for SMA: A Market Game-Changer? - TipRanks

2 days ago

Biogen’s Pivotal Study on ThecaFlex DRx™ System for SMA: A Market Game-Changer...

Biogen’s Lecanemab Study: A Potential Game-Changer in Alzheimer’s Treatment? - TipRanks

2 days ago

Biogen’s Lecanemab Study: A Potential Game-Changer in Alzheimer’s Treatment?  TipRanks

Sage’s Search for Lifeline Ran Into Defiant Biogen CEO - BioSpace

2 days ago

Sage’s Search for Lifeline Ran Into Defiant Biogen CEO  BioSpace

New York State Teachers Retirement System Has $14.73 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

2 days ago

New York State Teachers Retirement System Has $14.73 Million Stock Holdings in...